Compare iShares Russell 2000 ETF (IWM) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Russell 2000 ETF vs Nuwellis Inc — how do they compare? iShares Russell 2000 ETF trades at $301.52, while Nuwellis Inc trades at $1.49 (market cap $522.76K). The key difference: iShares Russell 2000 ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| IWM | NUWE | |
|---|---|---|
52-Week High | $301.69 | $220.50 |
52-Week Low | $225.45 | $1.42 |
Market Cap | — | $522.76K |
Sector | — | Technology |
Enterprise Value | — | -$1.29M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IWM, the iShares Russell 2000 ETF, trades at $301.53, up 1.11% on the day, with a bullish technical signal from moving averages and neutral oscillators. The ETF tracks US small-cap stocks, which have shown strong performance in 2026, though financial ratios are not applicable as it is a fund. Recent news highlights institutional inflows and small-cap outperformance versus large caps.
Outlook for IWM is positive due to small-cap strength and institutional support, but risks include higher volatility and competition from alternative ETFs. The bullish trend may continue if economic conditions favor small companies, though overbought RSI levels suggest potential near-term pullbacks.
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Russell 2000 ETF
The ETF is designed to track the performance of the securities and the stocks in the Russell 2000 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on IWM →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
